Case Control Study
Copyright ©The Author(s) 2023.
World J Crit Care Med. Jun 9, 2023; 12(3): 165-175
Published online Jun 9, 2023. doi: 10.5492/wjccm.v12.i3.165
Table 5 Antibiotics sensitivity percentage of the common gram-negative causative organisms for ventilator-associated pneumonia in our study, n (%)
Antimicrobial agent
Acinetobacter baumannii
Klebsiella pneumoniae
Stenotrophomonas maltophilia
Pseudomonas aeruginosa
Number of organisms19 (50)8 (42)5 (26)3 (16)
Ceftazidime1 (5.2)01 (20)3 (100)
Trimethoprim/sulfamethoxazole7 (37)4 (50)5 (100)-
Levofloxacin01 (12.5)5 (100)-
Minocycline--5 (100)-
Piperacillin-tazobactam1 (5.2)0-3 (100)
Cefepime1 (5.2)1 (12.5)-3 (100)
Meropenem1 (5.2)1 (12.5)-2 (66.6)
Imipenem1 (5.2)1 (12.5)-2 (66.6)
Ertapenem1 (5.2)1 (12.5)-2 (66.6)
Colistin19 (100)5 (62.5)-3 (100)
Gentamicin7 (37)3 (37.5)-3 (100)
Amikacin7 (37)3 (37.5)-3 (100)
Ciprofloxacin1 (5.2)1 (12.5)-3 (100)
Tigecycline4 (21)7 (87.5)--
Ampicillin ----
Amoxiclav -1 (12.5)--
Cefuroxime -1 (12.5)--
Ceftriaxone -1 (12.5)--